Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is “One to Watch”
H1 2019 results reflect excellent operational execution: lowest cost of cultivation per gram among publicly reporting Canadian LPs, industry-leading adjusted gross margin and adjusted EBITDA (positive adjusted EBITDA for 3rd consecutive quarter in Q2 2019) On track to increase target production capacity to 113,000 kg/year by the end of 2019 Well-positioned for Canada’s new edibles and derivative legalization expected in October 2019 with expanding production capacity, R&D and various strategic partnerships Invested in biosynthesis to produce cannabinoids without growing the plant at a fraction of cultivation costs Focused on developing further international partnerships, prioritizing the CBD market Organigram Holdings Inc.…